In the fast-paced world of tech innovation, research and development (R&D) is the fuel of disruption. But for Australian startups working with international partners, navigating the R&D tax incentive landscape can feel like decoding a foreign language. The good news? With the right structure, your startup can innovate locally while tapping into global capital—and still claim valuable tax offsets.
The Global R&D Playbook
Let’s say you’re an Australian startup working with a UK-based parent company or investor. You’re developing cutting-edge AI, biotech, or clean energy solutions right here in Sydney or Perth. Can you still claim the R&D tax incentive? The answer is yes—but only if you play by the rules.
Here’s the cheat sheet:
- Location matters: All R&D activities must be conducted in Australia or its external territories.
- Ownership and control: The foreign corporation must be connected to you (think parent company or affiliate), and you must have a binding agreement that clearly outlines who’s doing what.
- Benefit test: The R&D must be conducted for the foreign corporation—but not for just anyone. If another entity benefits significantly, you could lose eligibility.
What You Can (and Can’t) Claim
Let’s break it down:
✅ Claimable:
- Core R&D activities done in Australia
- Supporting R&D activities tied to those core activities (also done in Australia)
❌ Not Claimable:
- Any R&D done overseas for a foreign company
- Supporting activities in Australia linked to overseas core R&D
- R&D done for a foreign entity that isn’t a corporation or isn’t connected to you
ATO’s Watchful Eye: New Taxpayer Alerts
In December 2023, the ATO released two taxpayer alerts—TA 2023/4 and TA 2023/5—highlighting arrangements that may disqualify R&D claims:
- TA 2023/4 focuses on R&D conducted by associated entities. If your startup is claiming offsets for R&D done by a related party (like a parent company or affiliate), the ATO may scrutinise whether the work was genuinely done for your benefit or theirs. If the latter, your claim could be denied.
- TA 2023/5 targets overseas R&D conducted for foreign entities. Even if you have an overseas finding, if the ATO determines that the foreign entity is the main beneficiary—especially where it owns the IP or funds the R&D—your claim may not meet the “conducted for” test under section 355-210 of the ITAA 1997.
These alerts reinforce the importance of ensuring that R&D activities are not only conducted in Australia but also genuinely for the benefit of the Australian R&D entity, with financial risk and IP ownership clearly aligned.
Real-World Startup Scenarios
Example 1: The Ideal Setup
Company K, an Aussie startup, is a subsidiary of UK-based Company J. They’ve inked a deal: Company K does all R&D in Perth, and Company J gets the IP. The deal is arm’s length, and Company J pays regardless of success. Result? Company K can claim the R&D tax incentive.
Example 2: The Cautionary Tale
Company A, another Aussie startup, is fully funded and controlled by its UK parent, Company O. It subcontracts all R&D, some of which is done overseas. While it can claim for the Australian core R&D, it loses out on the overseas spend and must settle for a non-refundable offset due to its high aggregated turnover.
The Aggregated Turnover Trap
Here’s where many startups slip: if your foreign partner is connected to you, their revenue counts toward your aggregated turnover. If that pushes you over the $20 million threshold, you’re no longer eligible for the refundable offset—only the non-refundable one.
Startup Takeaway: Structure Smart, Scale Global
For founders and CFOs, the message is clear: structure your R&D agreements with precision. Keep your core innovation in Australia, ensure your contracts are airtight, and understand who really benefits from your breakthroughs.
With the ATO’s increased scrutiny on foreign-owned and associated-entity R&D arrangements, startups must be more diligent than ever. In a world where capital is global but incentives are local, smart structuring can mean the difference between a missed opportunity and a major tax win.
👉 Want help with your Industry Growth Program application? Book a free no obligation session with our R&D Tax, Grants & Incentive consultants today.
